Compare WYETH LTD with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PFIZER - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PFIZER WYETH LTD/
PFIZER
 
P/E (TTM) x 27.7 39.0 71.2% View Chart
P/BV x 5.3 6.6 81.3% View Chart
Dividend Yield % 1.3 0.5 245.1%  

Financials

 WYETH LTD   PFIZER
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PFIZER
Mar-19
WYETH LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0443,840 27.2%   
Low Rs8182,080 39.3%   
Sales per share (Unadj.) Rs298.6455.0 65.6%  
Earnings per share (Unadj.) Rs57.293.8 61.0%  
Cash flow per share (Unadj.) Rs58.4109.4 53.4%  
Dividends per share (Unadj.) Rs17.0022.50 75.6%  
Dividend yield (eoy) %1.80.8 240.2%  
Book value per share (Unadj.) Rs249.5658.2 37.9%  
Shares outstanding (eoy) m22.7245.75 49.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.16.5 47.9%   
Avg P/E ratio x16.331.6 51.5%  
P/CF ratio (eoy) x15.927.1 58.9%  
Price / Book Value ratio x3.74.5 83.0%  
Dividend payout %29.724.0 123.8%   
Avg Mkt Cap Rs m21,157135,420 15.6%   
No. of employees `0000.52.6 18.7%   
Total wages/salary Rs m4003,238 12.4%   
Avg. sales/employee Rs Th13,787.47,911.4 174.3%   
Avg. wages/employee Rs Th813.01,230.9 66.1%   
Avg. net profit/employee Rs Th2,643.31,630.7 162.1%   
INCOME DATA
Net Sales Rs m6,78320,815 32.6%  
Other income Rs m3531,674 21.1%   
Total revenues Rs m7,13622,489 31.7%   
Gross profit Rs m1,6175,712 28.3%  
Depreciation Rs m27714 3.7%   
Interest Rs m673 7.5%   
Profit before tax Rs m1,9386,599 29.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6322,309 27.4%   
Profit after tax Rs m1,3014,291 30.3%  
Gross profit margin %23.827.4 86.9%  
Effective tax rate %32.635.0 93.3%   
Net profit margin %19.220.6 93.0%  
BALANCE SHEET DATA
Current assets Rs m6,98427,167 25.7%   
Current liabilities Rs m2,0568,917 23.1%   
Net working cap to sales %72.687.7 82.9%  
Current ratio x3.43.0 111.5%  
Inventory Days Days9968 146.4%  
Debtors Days Days2430 79.5%  
Net fixed assets Rs m2448,862 2.8%   
Share capital Rs m227458 49.7%   
"Free" reserves Rs m5,44129,656 18.3%   
Net worth Rs m5,66830,113 18.8%   
Long term debt Rs m2525 100.0%   
Total assets Rs m7,90139,400 20.1%  
Interest coverage x353.391.5 386.1%   
Debt to equity ratio x00 531.3%  
Sales to assets ratio x0.90.5 162.5%   
Return on assets %16.511.1 149.3%  
Return on equity %22.914.2 161.0%  
Return on capital %34.022.1 153.8%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m15428 3.5%   
Fx outflow Rs m2,677786 340.4%   
Net fx Rs m-2,662-358 743.4%   
CASH FLOW
From Operations Rs m923978 94.4%  
From Investments Rs m317351 90.2%  
From Financial Activity Rs m-481-1,099 43.8%  
Net Cashflow Rs m759231 328.9%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 63.9 80.0%  
Indian inst/Mut Fund % 11.3 7.5 150.7%  
FIIs % 7.2 4.9 146.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 23.7 128.3%  
Shareholders   21,978 85,207 25.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  GSK PHARMA  J.B.CHEMICALS  SHASUN PHARMA  

Compare WYETH LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Economic Growth and Stock Markets: It's Not All Gloom and Doom(Podcast)

In addition to the usual stock market updates of the week, I talk about how RBI's monetary policy decision and slowing economy impacts you and your portfolio of stocks.

Related Views on News

DIVIS LABORATORIES at All Time High; BSE HEALTHCARE Index Up 0.6% (Market Updates)

Dec 6, 2019 | Updated on Dec 6, 2019

DIVIS LABORATORIES share price has hit an all time high at Rs 1,824 (up 1.0%). The BSE HEALTHCARE Index is up by 0.6%. Among the top gainers in the BSE HEALTHCARE Index today are DIVIS LABORATORIES (up 1.0%) and PFIZER (up 1.0%). The top losers include AJANTA PHARMA and BLISS GVS PHARMA .

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

How We Made 12.68% in One Overnight Trade(The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

The Best Trading Strategy for Fast Profits

Nov 29, 2019

Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - WOCKHARDT COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS